Epidemiology of malaria in South Africa: From control to elimination
1 Malaria Research Unit, South African Medical Research Council, Durban, South Africa
2 Malaria Directorate, National Department of Health, Pretoria, South Africa
3 School of Public Health Medicine, University of Newcastle, New South Wales, Australia
4 Malaria Control Programme, Polokwane, Limpopo Province, South Africa
of Infectious Diseases and Epidemiology, London School of
Hygiene and Tropical Medicine, London, United Kingdom
Locally specific epidemiological understanding is pivotal to
the success of malaria elimination in South Africa. Here, we
focus on how the host, vector, parasite and environment and
their interactions have influenced malaria incidence in South
Africa between 1995 and 2012. Broad environmental considerations
are necessary, including the physical (temperature and
humidity), social (migration patterns), economic (quality of
housing stock) and political (regional collaboration).
S Afr Med J 2013;103(10 Suppl 2):779-783.
1. Current malaria epidemiology
A detailed understanding of an infectious agent’s
epidemiology is essential for effectively targeting disease
control and elimination measures.1 Accordingly,
locally specific epidemiological understanding is pivotal to
the success of malaria elimination in South Africa (SA).
2. Morbidity and mortality
Malaria is endemic in northeastern areas of KwaZulu-Natal
(KZN), Mpumalanga and Limpopo provinces. As a result of
sustained vector control and case management, annual cases were
sustained below 10 000 for many years, with approximately
8 750 notified cases in 1995. With decreased insecticide
and treatment efficacy, malaria cases and deaths increased
sharply from 1996, peaking in 2000. In 1996 malaria cases
increased by 67% compared with the previous year, rising to over
60 000 cases in 2000 when more than 400 deaths were
recorded (Fig. 1). The loss of sulphadoxine-pyrimethamine (SP)
efficacy may have contributed to the huge increase in deaths
during this time period. Following the introduction of an
effective insecticide, artemisinin-containing combination
treatment (ACT) and the adoption of regional malaria control
strategies in SA, Swaziland and Mozambique, national case
numbers decreased to 26 506 in 2001 and continued to
decrease to <10 000 by 2011 (Fig. 1).
Fig. 1. Malaria cases and deaths reported in South Africa, 1995 - 2011 (source: Malaria Research Unit, Medical Research Council).
2.1 Morbidity and mortality in the provinces
Over the 10-year study period, the total number of reported
malaria cases decreased markedly from 64 622 in 2000 to
8 066 in 2010 (Fig. 2). The largest decrease was noted in
KZN, with this province reporting the lowest number of cases in
2010 (Fig. 2). Although case numbers in Limpopo declined from
9 487 in 2000 to 4 215 in 2010, this province has
become the largest contributor to malaria incidence of the three
endemic provinces (Fig. 2). Similar to malaria case numbers,
malaria-related mortality decreased during the study period,
from 459 deaths in 2000 to 87 deaths in 2010 (Fig. 2). Again,
the province associated with the greatest decline in
malaria-associated deaths was KZN, while the highest number of
deaths in 2010 was reported in Limpopo (Fig. 2).
Fig. 2. Number of malaria cases and malaria deaths by year and malaria-endemic province.
3. Factors favouring malaria transmission
3.1 Parasitology and drug resistance
The causative agent in over 90% of the malaria infections in SA has been and remains Plasmodium falciparum. Although extremely virulent, P. falciparum malaria infection rates were suppressed by effective control measures until the early 1980s.2 , 3 SA implemented a monitoring system to regularly review the in vitro effectiveness of first-line treatment and interpret the potential contribution of drug resistance to changing trends in malaria incidence. This approach has ensured the availability of good quality data to facilitate evidence-based decision-making on drug treatment.
Between 1980 and 1987, case numbers and chloroquine treatment failures in KZN Province increased sharply, principally due to the emergence of chloroquine-resistant parasites,4 prompting a drug policy change. SP replaced chloroquine as first-line treatment in the province in 1998, initially resulting in a decline in case numbers. Unfortunately, the development of SP-resistant parasites5 , 6 led to an increase in malaria case numbers which peaked during the 1999/2000 malaria season in KZN.7] The deployment of ACT, using artemether-lumefantrine, in 2001 ensured a dramatic decline in malaria cases numbers, which has been sustained.8
Parasites in both
Mpumalanga and Limpopo provinces remained susceptible to
chloroquine until the mid- to late-1990s. In response to
increasing numbers of chloroquine-resistant parasites, SP
became the antimalarial of choice in Mpumalanga Province in
1997 and Limpopo Province in 1998.2 SP remained efficacious in these
provinces for over 12 years before increases in both SP
treatment failures and parasites carrying SP resistance
markers were detected. 9-11 Artemether-lumefantrine became
the drug of choice in both these provinces in 2003.12 Currently P.
falciparum parasites in SA appear to be
susceptible to artemisinin derivatives and most of their
The predominant malaria vectors in SA belong to the Anopheles gambiae and An. funestus complexes. Within the An. gambiae complex, only An. gambiae sensu stricto, An. arabiensis and An. merus have been implicated in local malaria transmission. An. gambiae s.s was eliminated from SA in the late 1960s and An. merus has previously only played a minor role in malaria transmission. An. arabiensis is thus the primary SA malaria vector.
An. funestus funestus is the only member of the An. funestus complex to be implicated in local malaria transmission and it was reported to be eliminated in 1974; however, it re-emerged in KZN in 1999 and was found to be resistant to the pyrethroid insecticide used for malaria control in that province. The reintroduction of dichlorodiphenyltrichloroethane (DDT) in 2000 resulted in this vector once again being eliminated from SA.
The entomology of malaria mosquitoes in SA has been well characterised.13 An. arabiensis is zoophilic, readily feeding on cattle or humans and is both endo- and exophagic. It has modified its behaviour to be mostly exophilic. Recently, An. merus mosquitoes have been found in increasing abundance and could become an increasingly important vector.13
Climate imposes distinct biological constraints on the malaria parasite and anopheline mosquito development and survival. Low temperatures slow the time to sporogony in the insect thereby reducing the probability of infectious mosquito survival. Low rainfall severely restricts potential vector breeding sites, with a major impact on vector abundance and vectorial capacity. 1 These climatic factors have restricted the area of SA suitable for malaria transmission to the southern periphery of the continent’s malaria-endemic zone.14 The temperate climate dictates that malaria occurrence is seasonal, restricted to the summer months when temperatures are ideal for vector survival.
Climate also affects inter-annual malaria case fluctuation, although this has been enormously tempered in recent years by the effective malaria prevention and control programme. Studies of the relationship between malaria transmission intensity and climatic factors have served to explain, predict and forecast the distribution and the case numbers in different locations at different times. Malaria incidence is significantly synchronised with the El Niño Southern Oscillation, with below average incidence during El Niño years and above average incidence during El Niña years.15 Modelling found that inter-annual incidence variation is driven by climatic factors. Temperature and rainfall were good predictors of incidence in a 30-year analysis of KZN data,3 and variation in rainfall was significantly correlated with annual malaria incidence rates in Mpumalanga Province. 16 In KZN, spatial heterogeneity in local malaria incidence was partly explained by differences in average local rainfall and temperature.17 The multi-factorial nature of malaria transmission has resulted in climatic models only having limited success in producing long and medium range forecasts of malaria case numbers and distribution.18
4. Social and economic aspects of malaria
Malaria has serious economic impacts in Africa, slowing economic growth and development and perpetuating the cycle of poverty. Malaria epitomises a disease of poverty, affecting primarily the poor who are resident in malaria-prone rural areas with poorly-constructed dwellings that offer few barriers against mosquitoes. The global and African distributions of malaria and poverty are sympatric. Limited formal education, poor engineering and construction, and inaccessibility of healthcare, contribute to increase malaria risk in impoverished rural populations. Community beliefs can affect control, with opposition to indoor spraying, or early treatment seeking, with delays occasioned by initial care provided by traditional healers.
During periods when malaria
control was inadequate in SA, it posed a considerable burden on
the economy of affected provinces through lost productivity,
reduced tourism, and direct expenditure on healthcare provision
and control programme delivery.
5. Impact of case management with the rational use of drugs and rapid diagnostic tests
Comprehensive systematic reviews of all malaria deaths in two
SA provinces, Mpumalanga and Limpopo, demonstrated that delays
in malaria diagnosis and initiating appropriate therapy were key
contributors to preventable malaria deaths. Failed
first-line malaria therapy and health system weaknesses,
particularly in ensuring availability of appropriate
antimalarial drugs were implicated in avoidable treatment delay.
Malaria epidemiology in SA has been revolutionised by the
availability of prompt accurate diagnosis, particularly through
programme-wide implementation of rapid diagnostic tests (RDTs).
Similarly assured access to therapy, demonstrated to be
effective against locally circulating parasites, has been a key
determinant of epidemiological trends. These factors influence
the scale of the parasite reservoir, impact on absolute case
numbers, confound the interpretation of epidemiological trends
and have a detrimental impact on disease outcomes.
6. Timely diagnosis
There is an established precedent of confirming all malaria diagnoses in SA, rather than relying on clinical signs alone. Historically, malaria diagnosis in the malaria-endemic provinces relied upon the examination of blood smears. This resulted in delays in diagnosis and the quality of microscopy was enormously variable with poor diagnostic concordance found between diagnostic services.20 Delays in diagnosis contributed to higher case fatality ratios19 and treatment delays which resulted in increased gametocytes thereby contributing to higher transmission potential.
The field testing of immunochromatographic RDTs for malaria diagnosis in Mpumalanga Province provided compelling evidence of their high sensitivity and specificity during field use by clinical and malaria field staff.21 , 22 Their utility, accuracy and reliability, resulted in broad implementation as the first-line diagnostic method throughout malaria-endemic areas.22
This introduction of RDTs at
programme level was a first in Africa; until this point, RDTs
had only been used in small-scale field trials. The reliable
programme availability of RDTs was confirmed during the 1998 and
2009 national malaria reviews.
7. Drug stock-outs
Having an effective antimalarial drug on the formulary is necessary, but it is equally important that health staff are well educated on its correct use, that they rapidly initiate treatment and that the health system ensures its availability at all treatment sites.23 Community members need to trust the drug and health system reliability or they may seek alternative and often ineffective malaria treatment elsewhere, including traditional healers, resulting in higher rates of complicated disease and poor outcomes.24 Stock-outs of vital antimalarials result in increased malaria transmission with higher case numbers, and most importantly, disease progression with severe malaria.
A detailed study of
antimalarial drug management, supply and use was conducted in
KZN and Mpumalanga provinces.25 This study found common
deficiencies in inventory control systems, with the risk of
shrinkage and spoilage. Although standard treatment guidelines
and regular training were implemented in the public sector,
this was variable in the private sector. Exit interviews with
patients indicated that there was scope for improving
treatment information being provided. Patients had great trust
in public sector clinics for malaria treatment; thus, drug
supply systems must continually be assured. It was encouraging
to note that the 2009 national malaria programme review found
that stock-outs were uncommon.
8. Monitoring, evaluation and surveillance
Active and passive case reports are fed into provincial desktop malaria information systems (MIS) and then integrated nationally using a web-based platform. Cases diagnosed in clinics or hospitals are entered in registers and reported to district offices weekly. Details of cases diagnosed by RDT or microscopy by programme field staff are entered into the provincial MIS. This allows the automated or customised generation of aggregate daily, weekly, monthly, annual or seasonal reports at facility, locality, municipality (sub-district), district or provincial level. These data facilitate detailed planning and review at provincial level, and monitoring at national level. Ongoing system maintenance, data flow and quality control are affected at provincial level with national support.
Indoor residual spraying (IRS) activity is recorded on field
data cards, summarised by field managers and then entered into
the electronic data-management system. Captured data include
number of structures sprayed, type and quantity of insecticide
used, and locality of spraying. The electronic system generates
routine spraying coverage rates, insecticide use, spray
personnel activity and application rates. These reports assist
the planning of resource deployment and timing, and support
management through monitoring progress. Spatial decision support
allows malaria case mapping at district, sub-district, locality
and facility levels to enable interpretation of spatial disease
patterns. Mpumalanga Province also maps the source of infection.
9. Vector control
The mainstay of vector control is IRS application to the inner
walls of houses once or twice a year. Frequency depends on the
insecticide used, with different chemicals used for traditional
mud and thatch buildings and Western type structures. Over the
past seventy years, IRS has been a critical factor in decreasing
disease burden to levels that make elimination possible.
10. Insecticide resistance
An important challenge for
successful vector control is the development of insecticide
resistance in vectors. It appears that local resistance is
restricted to pyrethroids in An.
populations of An. arabiensis previously found to be resistant
to DDT were eliminated using carbamates. An. arabiensis in SA is currently susceptible
to all classes of insecticides. As current field research in
this area is limited, there is a risk of surreptitious
evolution of resistance without detection.
11. Cross-border malaria initiatives
SA shares borders with countries that have high malaria transmission burdens and poor malaria control. The potential exists for importation of insecticide resistant mosquitoes and/or drug resistant parasites that can cause focal outbreaks.
The Lubombo Spatial Development Initiative (LSDI) was an effective initiative between Mozambique, SA and Swaziland established to tackle high malaria incidence in northern KZN Province, eastern Swaziland and southern Mozambique. The malaria control interventions already existing in SA and Swaziland were strengthened, while simultaneously introducing integrated control in southern Mozambique. After five years the LSDI strategy had resulted in a decrease in malaria incidence of 99% in KZN, 98% in Swaziland and 92% in Maputo Province, Mozambique, compared with baseline levels in 2000.26
efforts could also potentially extend the effective life of
insecticides and drugs, by co-ordinating policy efforts.
12. Population migration
The high-volume migrancy across SA’s northern and eastern land borders places a continuing risk to non-immune border populations. Previous efforts to screen and treat malaria at ports of entry were thwarted by malaria smear turn-around times and informal border crossings and raises sensitivities around treatment strategies towards migrant populations.
Between January and December 2011, 64% (n=6 324) of all malaria cases reported were imported (Table 1), with 85% of cases in Gauteng, KZN and Mpumalanga originating in Mozambique. Thirty percent of imported cases in Limpopo, where the source was known, were from Mozambique, and 53% were from Zimbabwe. In areas receptive to malaria, where malaria vectors are present, imported malaria can contribute to local transmission.7
13. Malaria epidemics
Malaria epidemics are ‘an acute exacerbation of disease out of proportion to the normal to which the community is subject’. Epidemics are common only in zones of unstable malaria, where very slight modification in any of the transmission factors may completely upset equilibrium, and where the restraining influence of immunity may be negligible or absent, and they therefore show a very marked geographic distribution.1
Malaria-prone areas of SA meet all these criteria, and have experienced epidemics. The ‘restraining influence of immunity’ is largely absent in the local population, and climatic factors are sufficiently variable to cause substantial interannual variation in malaria incidence.3 Comprehensive malaria prevention through IRS and effective treatment with ACT has exerted another powerful ‘restraining influence’ on malaria epidemics in SA.2 Malaria epidemics thus reflect the interplay between partial or complete failure of malaria control measures and extreme weather conditions. The KZN epidemic of 1999/2000 provides an example of the effect of twin failures of IRS vector control due to pyrethroid resistance in An. funestus,27 and first-line antimalarial drug resistance.28 Once DDT was re-introduced for IRS and artemether-lumefantrine as first-line therapy, the epidemic was quickly controlled with malaria-related outpatient cases and hospital admissions falling by 99% in subsequent years.8
14. Current challenges
14.1 Malaria elimination status of the provinces
All 3 malaria-endemic provinces are at different phases within the malaria elimination continuum (Fig. 3).
In KZN, all districts have a
malaria case incidence of <1/1 000 population at risk;
therefore, this province as a whole meets the World Health
Organization (WHO) criteria to move from control to elimination
phases. Although the malaria transmission areas in Mpumalanga
have decreased greatly, two municipalities within the Ehlanzeni
District (Fig. 3) have malaria incidences that exceed the
elimination phase threshold. One area remains in the control
phase while the second falls into the pre-elimination category
(Fig. 3). The incidence of malaria in Limpopo has not
changed much over the study period (Fig. 3). The high-risk
area in Vhembe District has changed minimally since the
1999/2000 season and remains in the control phase. According to
the 1999/2000 malaria incidence map, 2/5 municipalities in
Mopani District were in the pre-elimination phase, one was in
the control phase while the remaining two areas were already in
the elimination phase. In the 2010/2011 map, the two areas in
the elimination phase remain unchanged, while the area in the
control phase has been elevated to pre-elimination status with
one of the 1999/2000 pre-elimination areas gaining an
As a result of these variances in
the status of the malaria-affected districts, uniform measures
cannot be implemented across the malaria-affected provinces.
This poses an additional challenge in that some districts are
further advanced than others. The elimination agenda cannot be
scaled up until all districts reach the elimination phase.
14.2 Migrating the malaria information system
The MIS is currently used in the three malaria-endemic
provinces in SA. Data are uploaded weekly by the information
officer to a central server housed at the South African Medical
Research Council in Durban. Data are further verified by the
staff in the database section before a web-based data (Malaria
Data Management System (MDMS)) warehouse is updated with the
latest datasets. The MDMS utilises business intelligence
technology to deliver the data in various reporting formats that
are used by various staff and researchers in the South African
14.3 Policies to support malaria elimination
It is widely accepted that malaria control and elimination programmes should be owned and led by governments. Appropriate policies need to be in place to cover the wide range of activities required for malaria elimination. These policies also need to be supported with the appropriate financial resources. Moreover, when capacities within governments are not adequate to serve the needs of a malaria elimination programme, then space must be created to allow non-governmental organisations, research and academia to come on board.
SA has been successful in ensuring that key commodities are in place and distributed to facilities (e.g. RDTs, drugs and insecticides) and that vector control teams are in place. SA faces its biggest challenge for elimination from the importation of malaria from its neighbouring countries, and polices and processes need to be in place to ensure cross-border collaboration and sharing of resources to enable optimal malaria coverage within SA and its neighbours.
The relationships between malaria
elimination and health systems strengthening require further
exploration in the SA context. In addition, the value and
engagement with non-governmental healthcare providers, and
outsourcing of malaria elimination functions, also needs to be
considered. The essential role of full participation and
engagement by communities is also required.
15. Transitioning to elimination
For SA the key challenges for moving the malaria elimination agenda, specifically on surveillance, are: transmission districts and localities that are still in the control phase of the WHO’s malaria elimination continuum; data quality and efficiency of data flows from peripheral to central levels; limited entomological surveillance to determining malaria hotspots; close proximity of the moderate-and high-transmission districts, and location in relation to neighbouring countries that have relatively higher burdens of malaria transmission; and regular monitoring for insecticide and drug resistance.
In SA the mainstay of the control programmes is indoor spraying
with a residual insecticide. This has been in place for the past
70 years and the only variable that has changed is the
insecticide used. Alternative and complementary measures are now
required to help get to zero cases.
The incidence of malaria mortality and morbidity has declined
remarkably over the past 12 years to such an extent that malaria
elimination is now possible in KZN and some districts of Limpopo
and Mpumalanga. There are a number of variables that drive
transmission in SA that enhance the relationship between the
host, vector and parasite. However, due to sustained malaria
vector control and improved case management, the number of local
cases has declined dramatically, an equilibrium has been
reached, and the reorientation of the malaria control programme
to an elimination one will assist in achieving zero
1. MacDonald G. The epidemiology and control of malaria. London: Oxford University Press,1957:45-62.
2. Craig MH, Kleinschmidt I, le Sueur D, Sharp BL. Exploring 30 years of malaria case data in KwaZulu-Natal, South Africa: Part II. The impact of non-climatic factors. Trop Med Int Health 2004;9:1258-1266. [http://dx.doi.org/10.1111/j.1365-3156.2004.01341.x]
3. Craig MH, Kleinschmidt I, le Sueur D, Sharp BL. Exploring 30 years of malaria case data in KwaZulu-Natal, South Africa: Part I. The impact of climatic factors. Trop Med Int Health 2004;9:1247-1257. [http://dx.doi.org/10.1111/j.1365-3156.2004.01340.x]
4. Freese JA, Sharp BL, Ngxongo SM, Markus MB. In vitro confirmation of chloroquine-resistant Plasmodium falciparum malaria in KwaZulu. S Afr Med J 1988;74(11):576-578
5. Bredenkamp BL, Sharp BL, Mthembu SD, Dürrheim DN, Barnes KI. Failure of sulfadoxine-pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal. S Afr Med J 2001;91:970-972.
6. Roper C, Pearce R, Bredenkamp B, et al. Antifolate antimalarial resistance in southeast Africa: A population-based analysis. Lancet 2003;361(9364):1174-1181.
7. Maharaj R, Morris N, Seocharan I, et al.The feasibility of malaria elimination in South Africa. Malaria J 2012;11:432. [http://dx.doi.org/10.1186/1475-2875-11-423]
8. Barnes KI, Chanda P, Barnabas G. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: Case studies of South Africa, Zambia and Ethiopia. Malar J 2009;8(Suppl 1):S8.[http://dx.doi.org/10.1186/1475-2875-8-S1-S8]
9. Govere JM, la Grange JJ, Dürrheim DN, et al. Sulfadoxine-pyrimethamine effectiveness against Plasmodium falciparum malaria in Mpumalanga Province, South Africa. Trans R Soc Trop Med Hyg 1999;93(6):644. [http://dx.doi.org/10.1016/S0035-9203(99)90082-2]
10. Mabuza A, Govere J, Dürrheim D, et al. Therapeutic efficacy of sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria 3 years after introduction in Mpumalanga. S Afr Med J 2001;91(11):975-978.
11. Mabuza A, Govere J, La Grange K, et al. Therapeutic efficacy of sulfadoxine-pyrimethamine for Plasmodium falciparum malaria. S Afr Med J 2005;95(5):346-349.
12. Williams HA, Dürrheim DN, Shretta R. The process of changing national malaria treatment policy – lessons from country-level studies. Health Policy Plan 2004;19(6):356-370. [http://dx.doi.org/10.1093/heapol/czh051]
13. Gillies MT, Coetzee MA Supplement to the Anophelinae of Africa South of the Sahara. Johannesburg: South African Institute for Medical Research, 1987.
14. Craig MH, Snow RW, le Sueur D. A climate-based distribution model of malaria transmission in sub-Saharan Africa. Parasitol Today 1999;15(3):105-111. [http://dx.doi.org/10.1016/S0169-4758(99)01396-4]
15. Mabaso ML, Kleinschmidt I, Sharp B, Smith T. El Nino Southern Oscillation (ENSO) and annual malaria incidence in Southern Africa. Trans R Soc Trop Med Hyg 2007;101(4):326-330. [http://dx.doi.org/10.1016/j.trstmh.2006.07.009]
16. Ngomane L, de Jager C. Changes in malaria morbidity and mortality in Mpumalanga Province, South Africa (2001-2009): A retrospective study. Malar J 2012;11:19. [http://dx.doi.org/10.1186/1475-2875-11-19]
17. Kleinschmidt I, Sharp BL, Clarke GP, Curtis B, Fraser C. Use of generalized linear mixed models in the spatial analysis of small-area malaria incidence rates in KwaZulu Natal, South Africa. Am J Epidemiol 2001;153(12):1213-1221. [http://dx.doi.org/10.1093/aje/153.12.1213]
18. Mabaso ML, Ndlovu NC. Critical review of research literature on climate-driven malaria epidemics in sub-Saharan Africa. Public Health 2012;126(11):909-919. [http://dx.doi.org/10.1016/j.puhe.2012.07.005]
19. Mehta U, Dürrheim DN, Blumberg L, et al. Malaria deaths as sentinel events to monitor healthcare delivery and antimalarial drug safety. Trop Med Int Health 2007;12(5):617-628. [http://dx.doi.org/10.1111/j.1365-3156.2007.01823.x]
20. Dürrheim DN, Becker PJ, Billinghurst K. Diagnostic disagreement – the lessons learnt from malaria diagnosis in Mpumalanga. S Afr Med J 1997;87(5):609-610.
21. La Grange JJP, Dürrheim DN, Govere J, Mngomezulu NM, Mabusa A. Field assessment of a combined immunochromatographic test for malaria diagnosis in Mpumalanga Province, South Africa. South Afr J Epidemiol Infect 1999;14(4):97-98.
22. Dürrheim DN, Govere JM, la Grange JJP, Mabuza A. Rapid immunochromatographic diagnosis and Rolling Back Malaria – experiences from an African control program. Afr J Med Med Sci 2001;30(Suppl):21-24.
23. Dürrheim DN, Williams HA. Assuring effective malaria treatment in Africa – drug efficacy is necessary but not sufficient. J Epidemiol Community Health 2005;59:178-180. [http://dx.doi.org/10.1136/jech.2004.020826]
24. Govere J, Dürrheim DN, la Grange JJP, Mabuza A, Booman M. Community knowledge and perceptions about malaria and practices influencing malaria control in Mpumalanga Province, South Africa. S Afr Med J 2000;90(6):611-616.
25. South East African Combination Anti-malarial Therapy (SEACAT). Interim Results: Antimalarial Management, Supply and Use in KwaZulu-Natal and Mpumalanga. http://www.malaria.org.za/Seacat/drug_utilisation_review.html (accessed 10 August 2013).
26. Sharp BL, Kleinschmidt I, Streat E, et al. Seven years of regional malaria control collaboration –Mozambique, South Africa and Swaziland. Am J Trop Med Hyg 2007;76(1):42-47.
27. Maharaj R, Mthembu DJ, Sharp BL. Impact of DDT re-introduction on malaria transmission in KwaZulu-Natal. S Afr Med J 2005;95(11):871-874.
28. Barnes KI, Durrheim DN, Little F, et al. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in Kwazulu-Natal, South Africa. PLoS Med 2005;2(11):e330. [http://dx.doi.org/10.1371/journal.pmed.0020330]
Full text views: 24789